PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 50 filers reported holding PASSAGE BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,000 | -60.0% | 20,435 | -48.0% | 0.00% | – |
| Q2 2023 | $30,000 | -18.9% | 39,323 | -18.0% | 0.00% | – |
| Q1 2023 | $37,000 | -26.0% | 47,983 | +12.0% | 0.00% | – |
| Q4 2022 | $50,000 | -2.0% | 42,834 | -17.9% | 0.00% | – |
| Q3 2022 | $51,000 | -58.9% | 52,157 | -5.1% | 0.00% | – |
| Q2 2022 | $124,000 | +3.3% | 54,983 | +35.5% | 0.00% | – |
| Q1 2022 | $120,000 | -35.8% | 40,577 | +44.0% | 0.00% | – |
| Q4 2021 | $187,000 | -12.6% | 28,170 | +30.0% | 0.00% | -100.0% |
| Q3 2021 | $214,000 | +20.2% | 21,669 | +61.7% | 0.00% | 0.0% |
| Q2 2021 | $178,000 | – | 13,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |